Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Optimization of Culture Conditions for Enrichment of Saccharomyces cerevisiae with Dl-α-Tocopherol by Response Surface Methodology.

Mohajeri Amiri M, Fazeli MR, Amini M, Hayati Roodbari N, Samadi N.

Iran J Pharm Res. 2017 Fall;16(4):1546-1554.

2.

Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.

Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA.

J Am Coll Nutr. 2017 Sep-Oct;36(7):497-506. doi: 10.1080/07315724.2017.1318724. Epub 2017 Jun 19.

PMID:
28628374
3.
4.

Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates.

Abdolvahab MH, Fazeli A, Halim A, Sediq AS, Fazeli MR, Schellekens H.

J Interferon Cytokine Res. 2016 Apr;36(4):247-57. doi: 10.1089/jir.2015.0108. Epub 2016 Feb 2.

PMID:
26835734
5.

An Albumin-Free Formulation for Escherichia coli-Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice.

Abdolvahab MH, Fazeli A, Radmalekshahi M, Nejadnik MR, Fazeli MR, Schellekens H.

J Interferon Cytokine Res. 2016 Mar;36(3):192-203. doi: 10.1089/jir.2015.0110. Epub 2016 Jan 29.

PMID:
26824268
6.

Preventing Aggregation of Recombinant Interferon beta-1b in Solution by Additives: Approach to an Albumin-Free Formulation.

Mahjoubi N, Fazeli MR, Dinarvand R, Khoshayand MR, Fazeli A, Taghavian M, Rastegar H.

Adv Pharm Bull. 2015 Nov;5(4):497-505. doi: 10.15171/apb.2015.068. Epub 2015 Nov 30.

7.

Development and Validation of a Micellar Capillary Electrophoresis Method for Determination of IFNβ-1b in Lyophilized Formulation of a Biosimilar Product.

Dadgarnejad M, Rastegar H, Ilka H, Shekarchi M, Adib N, Alebouyeh M, Keypour N, Shoeibi S, Kobarfard F, Fazeli MR.

Iran J Pharm Res. 2015 Summer;14(3):747-55.

8.

Isolation and structural characterization of Coryxin, a novel cyclic lipopeptide from Corynebacterium xerosis NS5 having emulsifying and anti-biofilm activity.

Dalili D, Amini M, Faramarzi MA, Fazeli MR, Khoshayand MR, Samadi N.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:425-32. doi: 10.1016/j.colsurfb.2015.07.005. Epub 2015 Jul 7.

PMID:
26280817
9.

Factors affecting viability of Bifidobacterium bifidum during spray drying.

Shokri Z, Fazeli MR, Ardjmand M, Mousavi SM, Gilani K.

Daru. 2015 Jan 25;23:7. doi: 10.1186/s40199-014-0088-z.

10.

A novel clot lysis assay for recombinant plasminogen activator.

Jamialahmadi O, Fazeli A, Hashemi-Najafabadi S, Fazeli MR.

Biotechnol Lett. 2015 Mar;37(3):593-600. doi: 10.1007/s10529-014-1711-2. Epub 2014 Oct 29.

PMID:
25351812
11.

Effect of arginine on pre-nucleus stage of interferon beta-1b aggregation.

Fazeli A, Haji-Abdolvahab M, Shojaosadati SA, Schellekens H, Khalifeh K, Moosavi-Movahedi AA, Fazeli MR.

AAPS PharmSciTech. 2014 Dec;15(6):1619-29. doi: 10.1208/s12249-014-0192-x. Epub 2014 Aug 21.

12.

The effects of dodecyl maltoside and sodium dodecyl sulfate surfactants on the stability and aggregation of recombinant interferon Beta-1b.

Haji Abdolvahab M, Fazeli A, Fazeli MR, Brinks V, Schellekens H.

J Interferon Cytokine Res. 2014 Nov;34(11):894-901. doi: 10.1089/jir.2013.0131. Epub 2014 Jun 23.

PMID:
24956236
13.

Probiotic Properties of Lyophilized Cell Free Extract of Lactobacillus casei.

Saadatzadeh A, Fazeli MR, Jamalifar H, Dinarvand R.

Jundishapur J Nat Pharm Prod. 2013 Aug;8(3):131-7. Epub 2013 Jul 23.

14.

The role of trehalose for metastable state and functional form of recombinant interferon beta-1b.

Fazeli A, Shojaosadati SA, Fazeli MR, Khalifeh K, Ariaeenejad S, Moosavi-Movahedi AA.

J Biotechnol. 2013 Feb 10;163(3):318-24. doi: 10.1016/j.jbiotec.2012.11.010. Epub 2012 Nov 23.

PMID:
23183384
15.

Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa.

Jamalifar H, Rahimi H, Samadi N, Shahverdi A, Sharifian Z, Hosseini F, Eslahi H, Fazeli M.

Iran J Microbiol. 2011 Mar;3(1):21-5.

16.

Evaluation of wound healing activities of kefir products.

Huseini HF, Rahimzadeh G, Fazeli MR, Mehrazma M, Salehi M.

Burns. 2012 Aug;38(5):719-23. doi: 10.1016/j.burns.2011.12.005. Epub 2012 Jan 10.

PMID:
22237053
17.

Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine.

Mahboubi A, Fazeli MR, Samadi N, Dinarvand R, Azadi S.

Iran J Pharm Res. 2012 Winter;11(1):39-46.

18.

Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.

Pourshahab PS, Gilani K, Moazeni E, Eslahi H, Fazeli MR, Jamalifar H.

J Microencapsul. 2011;28(7):605-13. doi: 10.3109/02652048.2011.599437. Epub 2011 Jul 27.

PMID:
21793647
19.

Biochemical and pathological evidences on the benefit of a new biodegradable nanoparticles of probiotic extract in murine colitis.

Saadatzadeh A, Atyabi F, Fazeli MR, Dinarvand R, Jamalifar H, Abdolghaffari AH, Mahdaviani P, Mahbod M, Baeeri M, Baghaei A, Mohammadirad A, Abdollahi M.

Fundam Clin Pharmacol. 2012 Oct;26(5):589-98. doi: 10.1111/j.1472-8206.2011.00966.x. Epub 2011 Jul 19.

PMID:
21771055
20.

Effect of probiotication on antioxidant and antibacterial activities of pomegranate juices from sour and sweet cultivars.

Fazeli MR, Bahmani S, Jamalifar H, Samadi N.

Nat Prod Res. 2011 Feb;25(3):288-97. doi: 10.1080/14786419.2010.495068.

PMID:
21294041
21.

Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.

Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H.

J Microencapsul. 2010;27(7):618-27. doi: 10.3109/02652048.2010.506579.

PMID:
20681747
22.

Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.

Gilani K, Moazeni E, Ramezanli T, Amini M, Fazeli MR, Jamalifar H.

J Pharm Sci. 2011 Jan;100(1):252-9. doi: 10.1002/jps.22274. Epub 2010 Jul 2.

PMID:
20602350
23.

Preparation and in-vitro Antibacterial Evaluation of Electroless Silver Coated Polymers.

Fazeli MR, Hosseini V, Shamsa F, Jamalifar H.

Iran J Pharm Res. 2010 Summer;9(3):259-64.

24.

Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial.

Mirmiran P, Fazeli MR, Asghari G, Shafiee A, Azizi F.

Br J Nutr. 2010 Aug;104(3):402-6. doi: 10.1017/S0007114510000504. Epub 2010 Mar 25.

PMID:
20334708
25.

Intra/extracellular biosynthesis of silver nanoparticles by an autochthonous strain of Proteus mirabilis isolated from photographic waste.

Samadi N, Golkaran D, Eslamifar A, Jamalifar H, Fazeli MR, Mohseni FA.

J Biomed Nanotechnol. 2009 Jun;5(3):247-53.

PMID:
20055006
26.

Synthesis and antimicrobial effects of silver nanoparticles produced by chemical reduction method.

Kheybari S, Samadi N, Hosseini SV, Fazeli A, Fazeli MR.

Daru. 2010;18(3):168-72.

27.

Selection for autochthonous bifidobacteial isolates adapted to simulated gastrointestinal fluid.

Jamalifar H, Bigdeli B, Nowroozi J, Zolfaghari HS, Fazeli MR.

Daru. 2010;18(1):57-66.

28.

Efficacy of detergents and fresh produce disinfectants against microorganisms associated with mixed raw vegetables.

Samadi N, Abadian N, Bakhtiari D, Fazeli MR, Jamalifar H.

J Food Prot. 2009 Jul;72(7):1486-90.

PMID:
19681275
29.

Live and heat-inactivated lactobacilli from feces inhibit Salmonella typhi and Escherichia coli adherence to Caco-2 cells.

Ostad SN, Salarian AA, Ghahramani MH, Fazeli MR, Samadi N, Jamalifar H.

Folia Microbiol (Praha). 2009;54(2):157-60. doi: 10.1007/s12223-009-0024-7. Epub 2009 May 6.

PMID:
19418255
30.

Aflatoxin B1 binding capacity of autochthonous strains of lactic acid bacteria.

Fazeli MR, Hajimohammadali M, Moshkani A, Samadi N, Jamalifar H, Khoshayand MR, Vaghari E, Pouragahi S.

J Food Prot. 2009 Jan;72(1):189-92.

PMID:
19205485
31.

Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.

Mahboubi A, Fazeli MR, Dinarvand R, Samadi N, Sharifzadeh M, Ilka H, Azadi S, Soleimanian R, Kalkouei H, Hajikhanmirzaei R, Valadkhani M.

Iran J Immunol. 2008 Sep;5(3):163-70. doi: IJIv5i3A4.

32.

Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance.

Mojtahedzadeh M, Panahi Y, Fazeli MR, Najafi A, Pazouki M, Navehsi BM, Bazzaz A, Naghizadeh MM, Beiraghdar F.

Int J Infect Dis. 2008 May;12(3):312-8. Epub 2007 Nov 26.

33.

Disinfection efficiency of irreversible hydrocolloid impressions using different concentrations of sodium hypochlorite: a pilot study.

Memarian M, Fazeli MR, Jamalifar H, Azimnejad A.

J Contemp Dent Pract. 2007 May 1;8(4):27-34.

PMID:
17486184
34.

Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.

Rafati MR, Rouini MR, Mojtahedzadeh M, Najafi A, Tavakoli H, Gholami K, Fazeli MR.

Int J Antimicrob Agents. 2006 Aug;28(2):122-7. Epub 2006 Jul 3.

PMID:
16815689
35.

Effects of salinity on beta-carotene production by Dunaliella tertiolecta DCCBC26 isolated from the Urmia salt lake, north of Iran.

Fazeli MR, Tofighi H, Samadi N, Jamalifar H.

Bioresour Technol. 2006 Dec;97(18):2453-6. Epub 2005 Dec 13.

PMID:
16356710
36.

Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.

Tehranchian S, Akbarzadeh T, Fazeli MR, Jamalifar H, Shafiee A.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1023-5.

PMID:
15686905
37.

Antimicrobial activity of crude methanolic extract of Satureja khuzistanica.

Amanlou M, Fazeli MR, Arvin A, Amin HG, Farsam H.

Fitoterapia. 2004 Dec;75(7-8):768-70.

PMID:
15567261
38.

Inhibition of nitrofurantoin reduction by menthol leads to enhanced antimicrobial activity.

Shahverdi AR, Fazeli MR, Rafii F, Kakavand M, Jamalifar H, Hamedi J.

J Chemother. 2003 Oct;15(5):449-53.

PMID:
14598936
39.

Group a streptococcal serotypes isolated from healthy schoolchildren in iran.

Fazeli MR, Ghaemi E, Tabarraei A, Kaplan EL, Johnson DR, Vakili MA, Khodabakhshi B.

Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):475-8. Epub 2003 Jul 18.

PMID:
12884067
40.

Depression of streptomycin production by Streptomyces griseus at elevated growth temperature: studies using gene fusions.

Deeble VJ, Lindley HK, Fazeli MR, Cove JH, Baumberg S.

Microbiology. 1995 Oct;141 ( Pt 10):2511-8.

PMID:
7582010

Supplemental Content

Loading ...
Support Center